NASDAQ:PLRZ Polyrizon (PLRZ) Stock Price, News & Analysis $1.09 +0.05 (+4.81%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Polyrizon Stock (NASDAQ:PLRZ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Polyrizon alerts:Sign Up Key Stats Today's Range$1.02▼$1.0950-Day Range$0.68▼$1.8852-Week Range$0.55▼$1,200.00Volume372,206 shsAverage Volume599,617 shsMarket Capitalization$6.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel. Read More Receive PLRZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polyrizon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PLRZ Stock News HeadlinesPolyrizon Regains Nasdaq ComplianceAugust 14, 2025 | msn.comPolyrizon Ltd. Regains Compliance with Nasdaq Listing RequirementsAugust 14, 2025 | quiverquant.comQA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and earning a reputation for fact-based analysis, not sensationalism. That’s why his latest economic warning is turning so many heads. In his new report, Louis reveals how recent policies are accelerating a massive economic shift. While headlines point to strong numbers, everyday Americans feel the squeeze as prices climb and industries are reshaped. According to Louis, this transformation could determine who falls behind — and who builds lasting wealth. | InvestorPlace (Ad)Polyrizon Regains Compliance with Nasdaq Listing RequirementsAugust 14, 2025 | globenewswire.comPolyrizon Ltd. Announces Special General Meeting for September 2025July 31, 2025 | tipranks.comPolyrizon stock soars after promising nasal allergy blocker test resultsJuly 23, 2025 | in.investing.comPolyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest StudyJuly 22, 2025 | globenewswire.comPolyrizon Ltd.: Polyrizon Retains Nasdaq Listing Following Hearings PanelJuly 15, 2025 | finanznachrichten.deSee More Headlines PLRZ Stock Analysis - Frequently Asked Questions How have PLRZ shares performed this year? Polyrizon's stock was trading at $542.50 at the beginning of 2025. Since then, PLRZ shares have decreased by 99.8% and is now trading at $1.09. When did Polyrizon's stock split? Shares of Polyrizon reverse split on Tuesday, May 27th 2025.A 1-250 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. When did Polyrizon IPO? Polyrizon (PLRZ) raised $4 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share. How do I buy shares of Polyrizon? Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:PLRZ Previous SymbolNASDAQ:PLRZ CIK1893645 Webwww.polyrizon-biotech.com Phone972-55-433-5665FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.16 Quick Ratio10.16 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$315.05 per share Price / Book0.00Miscellaneous Outstanding Shares5,990,000Free FloatN/AMarket Cap$6.53 million OptionableN/A BetaN/A Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:PLRZ) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredHave You Seen This? Trump Schedules 'Stock Market Reset' For Sept. 30Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.